Crossmark

GRIDSS2: comprehensive characterisation of somatic structural variation using single breakend variants and structural variant phasing

Published Online: 2021-07-12

Published Print: 2021-12

Authors

Cameron, Daniel L. https://orcid.org/0000-0002-0951-7116
Baber, Jonathan

Shale, Charles

Valle-Inclan, Jose Espejo

Besselink, Nicolle

van Hoeck, Arne

Janssen, Roel

Cuppen, Edwin

Priestley, Peter

Papenfuss, Anthony T.
Funding

Funding for this research was provided by:

National Health and Medical Research Council (1116955, 1188098)
License Information

Text and Data Mining valid from 2021-07-12

Version of Record valid from 2021-07-12
More Information

Article History

Received: 21 January 2021

Accepted: 30 June 2021

First Online: 12 July 2021

Declarations

:

: Patient data was obtained from the Hartwig Medical Foundation through data request DR-005 “Development and validation of tumor genome analysis tools.” The data access request was reviewed and approved by the Hartwig Medical Foundation Data Access Board, and all patient data has been used in accordance with informed consent given by the patients.

: The authors declare no competing financial interests.

Document is current